收藏商品
全国免费服务热线
4000-520-616
Selectiveinhibitorofpolo-likekinase1(PLK1)andpolo-likekinase3(PLK3)(IC50valuesare2.2and9.1nMrespectively).Displays>100-foldselectivityover~30otherkinasestestedincludingcdk1andcdk2.Inhibitsproliferationofmosttumorcellsinvitroandisselectiveovernormaldiploidfibroblasts.
SoldforresearchpurposesunderagreementfromGlaxoSmithKline
GW843682XisalsoofferedaspartoftheTocriscreenPlusandTocriscreenKinaseInhibitorToolboxI.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight477.46.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Lansingetal(2007)Invitrobiologicalactivityofanovelsmall-moleculeinhibitorofpolo-likekinase1.Mol.CancerTher.6450PMID:17267659
Keywords:GW843682X,supplier,Selective,inhibitors,inhibits,PLK1,PLK3,Mitosis,Polo-like,Kinases,GW843682X,GlaxoSmithKline,GSK,Polo-like,Kinase,Mitosis,Polo-like,Kinase,TocrisBioscience
极简而严谨,我们仅销售188款生物医学科研用品,款款都是爆款;因为少所以聚焦,聚焦甄选每一款产品,聚焦服务每一位客户!
关注我们 :
品质甄选,正品保证
自营电商,厂家直采
极简主义,188精品
公司版权所有 © 2005-2021 苏州蚂蚁淘生物科技有限公司 苏ICP备17049038号-10